SARATOGA, N.Y., June 3, 2026 /PRNewswire/ -- What is the best layout for a bathroom remodel? According to HelloNation, Jeff McDonald of McDonald Construction...
Upgraded four-stage cooling system and 7-zone support target the most common cause of disrupted sleep in American homesWILMINGTON, Del., June 3, 2026 /PRNewswire/ --...
Tokyo, Japan and Cambridge, UK, 2 June 2026 – Nxera Pharma Co., Ltd. (“Nxera” or the “Company”) announces that the Ministry of Food and Drug Safety (MFDS) of the Republic of Korea has granted Orphan Drug Designation (ODD) and Global Innovative Products on Fast Track (GIFT) designation to vamorolone for the treatment of Duchenne muscular dystrophy (DMD). The Company plans to submit a Marketing Authorization Application (MAA) for vamorolone in South Korea during 2026.
Breaking Cover at Monterey Car Week 2025, the Hybrid EREV Gyesera Begins Production in Q4/2025 and is the Long-Awaited Successor to the Innovative Revero
MONTEREY, Calif.,...
COPENHAGEN, Denmark, Aug. 12, 2025 /PRNewswire/ -- A field trial in Denmark shows Ambient Carbon's Methane Eradication Photochemical System (MEPS) eliminated up to 90%...
New Kestrel | Kyte LT and Hikelite LT join the line-up alongside updated best-sellers
CORTEZ, Colo., Aug. 11, 2025 /PRNewswire/ -- As the leader in both...
Group mine and milling outputs to lift, delivering improved free cash flow in FY26
PERTH, Western Australia, Aug. 7, 2025 /CNW/ - Westgold Resources Limited...
VANCOUVER, BC, Aug. 6, 2025 /PRNewswire/ - Gold Royalty Corp. ("Gold Royalty" or the "Company") (NYSE American: GROY) is pleased to announce the filing...
DOVER, Del., Aug. 5, 2025 /PRNewswire/ -- Diamond Porta Potty, a nationwide provider of portable restrooms, is spotlighting pivotal trends reshaping the portable sanitation...
LOS ANGELES, July 31, 2025 /PRNewswire/ -- CleaDeep, a leading kitchen appliance manufacturer, will officially make its debut at IFA 2025 from September 4 to...